NEW YORK, April 16, 2026 /PRNewswire/ -- Enhanced, the elite sports competition and direct-to-consumer products company, today offered its reaction to the United States Food & Drug Administration's (FDA) recent guidance clarifying the regulatory status of certain peptides currently on its Category 2 list. By reclassifying these peptides, the FDA is moving them out of the grey market and enabling consumers to access them via trusted healthcare professionals and through licensed compounding agents. This decision will bring more transparent regulation for licensed providers such as Enhanced, and we expect it will deepen its positioning in the market as a source for regulated performance and longevity protocols, particularly with a focus on peptides.
kAmQ(6 DEC@?8=J DFAA@CE E96 uspVD C646?E 8F:52?46 – 2 A@D:E:G6 C68F=2E@CJ DE6A 7@C E96 7FEFC6 @7 A6CD@?2=:K65 962=E942C6 7@4FD65 @? A6C7@C>2?46 2?5 =@?86G:EJ[Q D2:5 |2I:>:=:2? |2CE:?[ r9:67 tI64FE:G6 ~77:46C[ t?92?465] Q~FC 4@C6 AC:?4:A=6 :D E@ @A6C2E6 2E E96 9:896DE >65:42= 2?5 4=:?:42= DE2?52C5D @7 42C6 2?5 E9:D 564:D:@? 2==@HD t?92?465 E@ D276=J @776C 6=:E6 2E9=6E6D 2?5 4@?DF>6CD 2=:<6 2446DD E@ A6AE:56D E92E AC@G:56 :>>6?D6 G2=F6 7@C E96:C C64@G6CJ 2?5 A6C7@C>2?46] p55:E:@?2==J[ :E H:== A@H6C @FC 7=JH966= DEC2E68J @7 AC@AC:6E2CJ C6D62C49 52E2 86?6C2E65 7C@> 2E9=6E6 4=:?:42= EC:2=D D92A:?8 >@C6 AC64:D6 AC6D4C:AE:@? 8F:56=:?6D 7@C 4@?DF>6CD[ 2 5:776C6?E:2E65 >@56= E92E ?@ @E96C AC@G:56C :? E96 >2C<6E 42? @776C]Qk^Am
kAmpD AC6G:@FD=J 2??@F?465 @? |2C49 `gE9[ t?92?465 :D A=2??:?8 E@ @776C 2446DD E@ 255:E:@?2= A6AE:56D :? 244@C52?46 H:E9 E96 uspVD 8F:52?46] r6CE2:? A6AE:56D :>A24E65 3J E9:D C646?E C68F=2E@CJ 2??@F?46>6?E H:== 36 >256 2G2:=23=6 @? E96 {:G6 t?92?465 A=2E7@C> @?46 E96J 2C6 >@G65 E@ E96 r2E68@CJ ` =:DE]k^Am
kAmkDEC@?8mp3@FE t?92?465 {E5k^DEC@?8mk^Am
kAmt?92?465 :D 2? 6=:E6 DA@CED 4@>A6E:E:@? 2?5 A6C7@C>2?46 AC@5F4ED 4@>A2?J 4@>>:EE65 E@ 8:G:?8 2E9=6E6D 2?5 A6@A=6 2=:<6 2446DD E@ AC@5F4ED E92E @AE:>:K6 E96:C 962=E9[ A6C7@C>2?46 2?5 C64@G6CJ] %96 t?92?465 !6C7@C>2?46 !C@5F4E =:?6 AC@G:56D 4@?DF>6CD 2446DD E@ AC@5F4ED[ 2?5 AC@E@4@=D E92E @AE:>:K6 962=E9[ =@?86G:EJ 2?5 G:E2=:EJ] pD 2 AC6>:F> 3C2?5[ t?92?465 2:>D E@ C6G@=FE:@?:K6 2?5 =625 E96 !6C7@C>2?46 |65:4:?6 42E68@CJ]k^Am
kAmkDEC@?8mp3@FE %96 t?92?465 v2>6Dk^DEC@?8mk^Am
kAm%96 t?92?465 v2>6D H:== 492>A:@? D4:6?E:7:4 :??@G2E:@? 2?5 :?E68C:EJ :? 6=:E6 DA@CE:?8 4@>A6E:E:@?] t?92?465 36=:6G6D :? 2? @3;64E:G6[ 6G:56?46\32D65 2AAC@249 E@ 4@>A6E:E:@?[ @?6 E92E 46=63C2E6D 2E9=6E:4 6I46==6?46 2?5 F?=@4<D 2E9=6E6DV 7F== A@E6?E:2=] %96 t?92?465 v2>6D :D ?@E @?=J 4C62E:?8 2 DA@CE:?8 6G6?E E92E :D E9C:==:?8 7@C DA64E2E@CD 3FE 2=D@ 2 3624@? 7@C D4:6?E:7:4 EC2?DA2C6?4J 2?5 2E9=6E6 H6=72C6] qJ AFEE:?8 2E9=6E6D 7:CDE[ :E 8:G6D E96> E96 @AA@CEF?:EJ E@ C6249 E96:C 7F== A@E6?E:2= 2?5 36 4@>A6?D2E65 244@C5:?8=J[ 2== H9:=6 6?DFC:?8 E96:C D276EJ E9C@F89 C:8@C@FD >65:42= DFA6CG:D:@? 2?5 D4:6?E:7:4 @G6CD:89E] %96 :?2F8FC2= t?92?465 v2>6D H:== E2<6 A=246 @? |2J ac[ a_ae 2?5 H:== 36 96=5 2E 2 AFCA@D6\3F:=E 4@>A6E:E:@? 4@>A=6I 2E #6D@CED (@C=5 {2D '682D] %96 v2>6D H:== @776C F?AC64656?E65 7:?2?4:2= :?46?E:G6D E@ 2E9=6E6D]k^Am
kAmkDEC@?8mx?G6DE@C r@?E24Ek^DEC@?8mk^Am
kAmpD:2 v:=36CEk^Am
More from this section
kAmw625 @7 x?G6DE@C #6=2E:@?Dk^Am
kAmk2 9C67lQ>2:=E@i2D:2]8:=36CEo6?92?465]@C8Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm2D:2]8:=36CEo6?92?465]@C8k^2mk^Am
kAmkDEC@?8m|65:2 r@?E24Ek^DEC@?8mk^Am
kAmr9C:D y@?6Dk^Am
kAmr9:67 r@>>F?:42E:@?D ~77:46C[ t?92?465 v2>6Dk^Am
kAmk2 9C67lQ>2:=E@i>65:2o6?92?465]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm>65:2o6?92?465]4@>k^2mk^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?l}*beaf_U2>AjD5la_ae\_c\`eQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^6?92?465\C624ED\E@\FD\7@@5\\5CF8\25>:?:DEC2E:@?D\8F:52?46\@?\A6AE:56D\b_afccf`b]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^6?92?465\C624ED\E@\FD\7@@5\\5CF8\25>:?:DEC2E:@?D\8F:52?46\@?\A6AE:56D\b_afccf`b]9E>=k^2mk^Am
kAm$~&#rt t?92?465k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5l}*beaf_U2>Aj%C2?D>:DD:@?0x5la_ae_c`e_g_g!#0}t($0&$!#00000}*beaf_U2>Ajs2E6x5la_ae_c`eQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
